Detalhe da pesquisa
1.
CDK4/6 inhibition triggers anti-tumour immunity.
Nature
; 548(7668): 471-475, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813415
2.
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Breast Cancer Res
; 19(1): 23, 2017 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264701
3.
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.
Nat Cancer
; 2(1): 34-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33997789
4.
Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.
Cancer Discov
; 9(9): 1208-1227, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217296
5.
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest.
Trends Cell Biol
; 28(11): 911-925, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061045
6.
Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies.
PLoS One
; 13(6): e0198790, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897959
7.
Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer.
Cancer Res
; 78(18): 5300-5314, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30065048
8.
IL-1ß inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization.
Nat Cell Biol
; 20(9): 1084-1097, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154549
9.
Redox regulation of Rac1 by thiol oxidation.
Free Radic Biol Med
; 79: 237-50, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25289457
10.
Effector recruitment method to study spatially regulated activation of Ras and Rho GTPases.
Methods Mol Biol
; 1120: 263-83, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24470032
11.
The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.
Genes Cancer
; 4(11-12): 460-75, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24386507